Early Toxicity Testing Market Size 2019 by Top Key Players and Application with Trend and Growth by 2022 Forecasts

Toxins are substances that can adversely affect living organisms. They are present in a variety of products such as food additives, chemicals, pesticides, and cosmetics. During drug development, it was observed that approximately 26% of the products face rejection in the later stages of development due to safety issues. This leads to massive financial losses for many industries, which include pharmaceuticals and food industries.

Get the sample report: https://www.alliedmarketresearch.com/request-sample/619?utm_source=openpr_Niranjan

Early Toxicity Testing Market accounted for $614 million in 2015 and is anticipated to reach $1,012 million by 2022, registering a CAGR of 7.3% during the forecast period, 2016 to 2022, according to a new report published by Allied Market Research. Among different geographic regions, Europe is the largest contributor toward the early toxicity testing market; whereas, Asia-Pacific is the fastest growing region.

Early toxicity testing is used during clinical trials, where the toxicity of the compounds present in the test product is evaluated. Different tests are conducted to check the adverse effects of the compound on different aspects of human health. Some tests are also useful to check if the entity has toxic potentials such as genotoxicity, carcinogenicity, neurotoxicity, and systemic toxicity. These toxicity tests are important for the welfare of human health and the environment.

Purchase report @Discount: https://www.alliedmarketresearch.com/checkout/296350?utm_source=openpr_Niranjan

The increase in awareness among the regulatory authorities concerning the environment and human health welfare is the major factor that fuels the growth of this market. The early toxicity testing market experienced moderate growth in recent years due to the replacement of in vivo models by in vitro models and technological advancement in vitro and in silico techniques. However, certain limitations of preclinical trials and limited awareness about the benefits of using early toxicity tests are estimated to hamper market growth.

In vivo segment dominated the market with maximum share in 2015 and is anticipated to continue being the dominant segment in 2022 in terms of revenue. As the physiological properties of humans and animals are similar, the responses of the animals when exposed to test compounds are similar to the responses of humans. This aspect makes this technique a more reliable method for toxicity testing. In addition, this technique is a cost-effective way to test the toxicity of test entities.

The pharmaceutical industry is expected to be the fastest growing segment throughout the analysis period and accounts for almost two-thirds of the total share of the market in 2022. This is due to the increase in the number of clinical trials for drug development. During this process, early toxicity testing can help reduce the risk of later stage failure for drug development, which predominantly fuels the growth of the pharmaceutical industry market.

In 2015, Europe displayed maximum contribution in the early toxicity testing market in total revenue generated that year. Asia-Pacific region observes fast-paced growth in the early toxicity testing market registering a CAGR of 8.1%. A rise in disposable income, improvement in healthcare expenditure, an increase in the adoption rate of in vitro and in silico techniques are the major reasons for the growth of early toxicity testing market in the Asia-Pacific region.

Key Findings of the Early Toxicity Testing Market
• Genotoxicity is projected to be the fastest growing segment during the analysis period.
• The pharmaceutical industry was the highest revenue contributor by end users and is expected to continue its dominance throughout the forecast period.
• Europe dominated the global early toxicity testing market and is projected to grow at a CAGR of 6.6%.
• China is the fastest growing country in the Asia-Pacific region, registering a CAGR of 15.8% from 2016 to 2022.
• Cosmetic industry segment exhibits a fast-paced growth rate registering a CAGR of 9.8%.

The major companies profiled in the report include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Agilent Technologies Inc., Quest Diagnostics Incorporation, Merck & Co., Inc., Charles River Laboratories International Incorporation, Becton, Dickinson And Company, Danaher Corporation, Evotec Ag, and The Jackson Laboratory.

Chapter: 3 MARKET OVERVIEW

3.1. REPORT DESCRIPTION
3.2. KEY BENEFITS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PATENT ANALYSIS
3.3.1. Patent analysis by year
3.3.2. Patent analysis by region
3.4. GOVERNMENT REGULATIONS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Increased stringency of regulatory authorities concerning environment welfare
3.5.1.2. Replacement of in vivo models by in vitro model
3.5.1.3. Increased stringency of regulatory authorities concerning public health welfare
3.5.1.4. Adoption of early toxicity in order to reduce drug failure in later stages
3.5.2. Restraints
3.5.2.1. Limited awareness about the benefits of early toxicity testing
3.5.2.2. Limitation of preclinical testing
3.5.3. Opportunities
3.5.3.1. Advancement in silico platforms
3.5.3.2. Advancement in vitro models

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.